A systematic review 1 including 11 RCTs with a total of 9629 subjects (5228 receiving aspirin) was abstracted in DARE. The linear regression model confirmed that there is no linear dose-response trend, and the stratified Mantel-Haenszel test for heterogeneity confirmed that the RRs were similar across studies. The pooled RR across studies for any aspirin dose gave a risk reduction of 15% (95% CI 6% to 23%).
Primary/Secondary Keywords